Latest progress in the development of multitarget ligands for Alzheimer's disease based on the Hantzsch reaction

Future Med Chem. 2022 Jul;14(13):943-946. doi: 10.4155/fmc-2022-0080. Epub 2022 May 24.
No abstract available

Keywords: Alzheimer's disease; Hantzsch multicomponent reaction; calcium channel blockers.

Publication types

  • Editorial

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Calcium Channel Blockers / therapeutic use
  • Cholinesterase Inhibitors / therapeutic use
  • Humans
  • Ligands

Substances

  • Calcium Channel Blockers
  • Cholinesterase Inhibitors
  • Ligands